Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;43(6):699-713.
doi: 10.1007/s10735-012-9435-x. Epub 2012 Jun 30.

The role of CXC chemokines and their receptors in the progression and treatment of tumors

Affiliations
Review

The role of CXC chemokines and their receptors in the progression and treatment of tumors

Qingchao Zhu et al. J Mol Histol. 2012 Dec.

Abstract

Chemokines are a class of functional chemotactic peptides that contribute to a number of tumor-related processes. They are functionally defined as soluble factors that are able to control the directional migration of leukocytes, in particular, during infection and inflammation. It appears, however, that the biological effects mediated by chemokines are far more complex, and virtually all cells, including many tumor cell types, can express chemokines and chemokine receptors. A growing body of evidence indicates that they also contribute to a number of tumor-related processes, such as tumor cell growth, angiogenesis/angiostasis, local invasion, and mediate organ-specific metastases of cancer. The CXC chemokine class is a subfamily of a large family of chemokines. During the occurrence and development of tumor cells, this chemokine class is often accompanied by a series of molecular and biological changes. The CXC chemokine subfamily is closely related to the body's immune response to tumors and biological behaviors of tumors. In this paper, CXC chemokines and their role in the progression and treatment of tumors will be reviewed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Physiol. 1986 Dec;129(3):375-84 - PubMed
    1. Am J Pathol. 2012 Mar;180(3):1215-1222 - PubMed
    1. Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1186-92 - PubMed
    1. J Cell Biochem. 1990 Dec;44(4):207-19 - PubMed
    1. Cancer Res. 2001 Mar 1;61(5):2183-8 - PubMed

LinkOut - more resources